Finance

Lists
603998:SHA
Hunan Fangsheng Pharmaceutical Co Ltd
CN¥10.36
+0.97%
(+0.100) 1D
Sep 30, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603998...
Open
CN¥10.25
High
CN¥10.41
Low
CN¥10.25
Mkt. cap
4.55B
Avg. vol.
12.04M
Volume
0.00
Dividend
4.83%
Quarterly dividend
CN¥0.13
Ex-dividend date
Sep 11, 2026
P/E ratio
13.69
52-wk high
CN¥13.50
52-wk low
CN¥8.64
EPS
CN¥0.76
Shares outstanding
418.43M
No. of employees
2K
Open
CN¥10.25
High
CN¥10.41
Low
CN¥10.25
Mkt. cap
4.55B
Avg. vol.
12.04M
Volume
0.00
Dividend
4.83%
Quarterly dividend
CN¥0.13
Ex-dividend date
Sep 11, 2026
P/E ratio
13.69
52-wk high
CN¥13.50
52-wk low
CN¥8.64
EPS
CN¥0.76
Shares outstanding
418.43M
No. of employees
2K
News stories
From web sources and news partners
About Hunan Fangsheng Pharmaceutical Co Ltd
CEO-
Employees1.87K
FoundedOct 13, 1997
Headquarters-
SectorPharmaceutical industry
Websitefangsheng.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
419.07M
493.13M
462.77M
494.97M
Cost of goods sold
111.47M
136.60M
114.17M
118.07M
Cost of revenue
111.47M
136.60M
114.17M
118.07M
Research and development expenses
39.99M
46.39M
36.18M
34.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
176.10M
234.51M
200.92M
224.61M
Operating expense
210.66M
306.97M
243.57M
271.28M
Total operating expenses
322.13M
443.57M
357.74M
389.35M
Operating income
96.94M
49.55M
105.03M
105.63M
Other non operating income
-7.18M
5.51M
-166.90K
-35.30K
EBT including unusual items
112.67M
54.08M
103.64M
129.69M
EBT excluding unusual items
88.03M
52.08M
103.55M
125.59M
Income tax expense
13.81M
16.79M
15.78M
18.58M
Effective tax rate
12.26%
31.06%
15.22%
14.32%
Other operating expenses
115.73K
18.25M
6.32M
11.25M
Net income
99.04M
38.10M
88.39M
109.27M
Net profit margin
23.63%
7.73%
19.10%
22.08%
Earnings per share
-
-
-
-
Interest and investment income
1.79M
216.57K
1.03M
22.35M
Interest expense
-3.52M
-3.12M
-2.34M
-2.34M
Net interest expenses
-1.73M
-2.90M
-1.31M
20.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
115.21M
68.57M
124.05M
125.11M
Gain or loss from assets sale
20.67M
-51.39M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps